BeOne Medicines (ONC)
268.20
+3.72 (1.41%)
Upcoming Events
Latest Headlines
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Ball Titus B.
June 15, 2026 5:55 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Wang Lai
June 15, 2026 5:55 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Rosenberg Aaron
June 15, 2026 5:55 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Lee Chan Henry
June 15, 2026 5:55 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Wu Xiaobin
June 15, 2026 5:55 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Wang Xiaodong
June 15, 2026 5:55 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: OYLER JOHN
June 15, 2026 5:55 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: BRANDICOURT OLIVIER
June 15, 2026 5:51 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: HOOPER ANTHONY C
June 15, 2026 5:51 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Mooney Elizabeth Fisher
June 15, 2026 5:51 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Dugan Margaret
June 15, 2026 5:51 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Sawyers Charles Lazelle
June 15, 2026 5:50 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Sharp Shalini
June 15, 2026 5:49 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: Riva Alessandro
June 15, 2026 5:49 PM - SEC Filing
Form 3 BeOne Medicines Ltd. For: Jun 11 Filed by: Sawyers Charles Lazelle
June 15, 2026 5:45 PM - SEC Filing
Form 3 BeOne Medicines Ltd. For: Jun 11 Filed by: Mooney Elizabeth Fisher
June 15, 2026 5:42 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 11 Filed by: 667, L.P.
June 15, 2026 4:38 PM - SEC Filing
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026
June 12, 2026 6:00 AM - BizWire
BeOne presents phase 3 data showing BRUKINSA benefits in elderly CLL patients
June 11, 2026 7:24 AM - StreetInsider
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
June 11, 2026 7:24 AM - BizWire
Form 4 BeOne Medicines Ltd. For: Jun 08 Filed by: Ball Titus B.
June 10, 2026 5:27 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 08 Filed by: Lee Chan Henry
June 10, 2026 5:27 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 08 Filed by: Wang Lai
June 10, 2026 5:25 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 08 Filed by: Wu Xiaobin
June 10, 2026 5:24 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 08 Filed by: OYLER JOHN
June 10, 2026 5:22 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 01 Filed by: Yi Qingqing
June 3, 2026 4:10 PM - SEC Filing
BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens
June 3, 2026 4:41 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $436 at RBC Capital
June 2, 2026 7:16 AM - StreetInsider
BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026
June 1, 2026 6:00 AM - BizWire
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
May 29, 2026 6:00 AM - BizWire
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
May 28, 2026 4:07 PM - StreetInsider
Form 4 BeOne Medicines Ltd. For: May 22 Filed by: Riva Alessandro
May 27, 2026 5:29 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: May 22 Filed by: Dugan Margaret
May 27, 2026 5:27 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: May 22 Filed by: Sanders Corazon (Corsee) D.
May 27, 2026 5:26 PM - SEC Filing
BeOne Medicines reports positive phase 3 cancer trial results
May 27, 2026 5:00 PM - StreetInsider
BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026
May 27, 2026 5:00 PM - BizWire
Form 4 BeOne Medicines Ltd. For: May 22 Filed by: 667, L.P.
May 27, 2026 4:54 PM - SEC Filing
BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 26, 2026 6:01 AM - BizWire
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
May 21, 2026 6:00 AM - BizWire
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
May 20, 2026 3:10 PM - StreetInsider
BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard
May 20, 2026 6:00 AM - BizWire
JPMorgan Reinstates BeOne Medicines (ONC) at Overweight
May 20, 2026 4:30 AM - StreetInsider
Form 3/A BeOne Medicines Ltd. For: Sep 27 Filed by: Sharp Shalini
May 15, 2026 4:43 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: May 13 Filed by: Lee Chan Henry
May 15, 2026 4:42 PM - SEC Filing
BeOne Medicines wins FDA approval for mantle cell lymphoma drug
May 13, 2026 1:28 PM - StreetInsider
BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
May 13, 2026 1:27 PM - BizWire
BeOne Medicines (ONC) PT Raised to $395 at Morgan Stanley
May 7, 2026 9:00 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $425 at RBC Capital
May 7, 2026 8:22 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $453 at Citi
May 7, 2026 7:37 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $413 at Truist Securities
May 7, 2026 7:11 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $420 at Guggenheim
May 7, 2026 6:39 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $409 at Barclays
May 7, 2026 4:00 AM - StreetInsider
BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates
May 6, 2026 6:00 AM - BizWire
FDA grants priority review to BeOne's cancer drug combination
April 29, 2026 6:00 AM - StreetInsider
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA
April 29, 2026 6:00 AM - BizWire
BeOne Medicines to Announce First Quarter 2026 Financial Results on May 6
April 22, 2026 6:01 AM - BizWire
BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens After PRMT5i Presentation
April 20, 2026 5:35 AM - StreetInsider
Form 4 BeOne Medicines Ltd. For: Apr 08 Filed by: Lee Chan Henry
April 10, 2026 5:40 PM - SEC Filing
BeOne Medicines (ONC) PT Lowered to $411 at Truist Securities
April 8, 2026 6:06 AM - StreetInsider
BeOne Medicines (ONC) PT Lowered to $423 at RBC Capital
April 7, 2026 9:05 AM - StreetInsider
Wolfe Research Starts BeOne Medicines (ONC) at Outperform
March 26, 2026 4:11 PM - StreetInsider
Jefferies says these are the best SMID-cap biotech stocks to buy
March 22, 2026 10:00 AM - StreetInsider
Full Article List
